Datwyler announced a collaboration with LTS Device Technologies, a developer of smart wearable devices for drug delivery, and Stevanato Group

A year of rapid electrification, rising quality demands and industrial scale-up. Discover the key trends shaping mobility, battery systems and how Datwyler is driving reliability into 2026.

Datwyler gained momentum in the first half of 2025 despite a challenging environment. In the Healthcare division, particularly the recovery in market demand and the successful ramp-up of new products had a positive impact. Despite muted demand caused by ongoing trade conflicts, Datwyler continues to drive high-margin, innovative projects in the Industrial division, with solid growth in the Food & Beverage segment. Currency-adjusted, revenue increased by 1.3% to CHF 563.0 million, and the EBIT margin improved to 12.2%. The ForwardNow transformation program is progressing according to plan.

Datwyler generated revenue of CHF 1'107.7 million and increased its adjusted EBIT margin to 10.7% in 2024, despite weak markets and tangibly negative currency effects. Solid free cash flow allows an unchanged cash dividend of CHF 3.20 per bearer share to be proposed to the Annual General Meeting. The «ForwardNow» transformation program will accelerate the planned growth in revenue and profitability. The one-off costs associated with this program had a negative impact of CHF 37.9 million on the result in the reporting year, with the reported EBIT amounting to CHF 80.2 million. Over the medium-term and in a normal operating environment, the company expects annual organic revenue growth in the higher single-digit percentage range and an EBIT margin of 17% plus. In light of market forecasts, Datwyler is cautiously optimistic and expects to see a continuous increase in revenue and profitability.